DKD is the principal cause of ESRD and remains one of the most prevalent complications among patients with T2DM.Hyperglycaemia is the main factor in the development and progression of DKD; once established, it triggers multiple pathogenic processes (eg, hypertension, altered tubuloglomerular feedback, renal hypoxia, lipotoxicity, inflammation), leading to a progressive decline in GFR.
At the recent Malaysia Myeloproliferative Neoplasms (MPN) Expert Forum webinar, Associate Professor Dr Haifa Kathrin Al-Ali, Senior Consultant of Haematology and Oncology and the head of the Krukenberg Cancer Center, University Hospital of Halle (Saale), Germany, presented the case for earlier treatment of myelofibrosis (MF) and better symptom management. The webinar was organized by Novartis in collaboration with the Malaysian Society of Haematology (MSH), and chaired by Dr Chew Lee Ping, Consultant Haematologist from Hospital Umum Sarawak.
During the EMPIRE Summit sponsored by Boehringer Ingelheim, two distinguished speakers shared their insights into the evolving treatment landscape of DKD. Topics discussed include the role of SGLT-2iin fulfilling the unmet needs in DKD management and how evidence of their cardio renal-protective effects have altered clinical practice guidelines globally.
Same-day pre-event screening for SARS-CoV-2 using antigen-detecting rapid diagnostic tests (Ag-RDT) may enable the resumption of large-scale indoor events which were halted or had their attendance capacity reduced during the COVID-19 pandemic, according to a study from Spain presented at ECCMID 2021.
A rapid and affordable test for diagnosing COVID-19 outside the walls of the healthcare units could improve case-finding, contact tracing, and infection control, says an expert during a pre-ECCMID 2021 session.
While RT-PCR is the current gold standard to confirm a SARS-CoV-2 infection, antigen rapid test (ART) for COVID-19 allows for quick detection of SARS-CoV-2 and thus fast triaging of infected patients requiring isolation at the population level, according to studies presented at ECCMID 2021.
Psoriasis is a chronic inflammatory skin disease and can be classified as ‘mild’, ‘moderate’, or ‘severe’. The management of psoriasis should always be based on its severity and individual patient preferences – it should not be more unpleasant than the disease itself. The two most commonly prescribed classes of topical treatment for psoriasis are vitamin D analogues and topical corticosteroids. In this case study, Dr Tan Wooi Chiang shares his clinical experience treating plaque psoriasis with a combined formulation of betamethasone dipropionate and calcipotriol monohydrate in a single spray foam (Enstilar® Foam, LEO Pharma).
Plaque psoriasis is the most common form of psoriasis and is characterised by sharply demarcated erythematous plaques. The first-line management of this condition is with topical treatments, including vitamin D analogues and topical corticosteroids. In this case study, Dr Tan Wooi Chiang shares his clinical experience treating plaque psoriasis with a combined formulation of betamethasone dipropionate and calcipotriol monohydrate in a single spray foam (Enstilar® Foam, LEO Pharma).
At the recent Adult Vaccine Online Academy program webinar supported by Pfizer, Dr Petrick Periyasamy, head of the Hospital Canselor Tuanku Muhriz UKM Infectious Diseases Unit, and Dr Charles Feldman, Distinguished Professor of Pulmonology at South Africa’s University of Witwatersrand, discussed issues surrounding adult pneumococcal vaccination.